← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Chimerna Therapeutics Inc.
New York, NY
$3,493,039
Total funding
8
Grants
Funding over time
peak $1.1M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,493,039 · 8
By mechanism
R43$1,994,963 · 7
R44$1,498,076 · 1
Investigators at Chimerna Therapeutics Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Next-generation RNA synthesis and labeling kits$600,998
R44 · FY2023 · GM
Next-generation RNA synthesis and labeling kits$586,018
R44 · FY2022 · GM
Circular mimics of Iron-response elements to inhibit ferroptosis$433,356
R43 · FY2021 · NS
Next-generation RNA synthesis and labeling kits$311,060
R44 · FY2024 · GM
Synthetic biology approaches for bio-orthogonal labeling of circular RNAs$302,605
R43 · FY2025 · GM
Development of circRNA manufacturing platform in yeast$297,608
R43 · FY2024 · TR
A Novel TDP-43-Targeting Circular RNA to Treat Amyotrophic Lateral Sclerosis (ALS)$256,158
R43 · FY2022 · NS
Circular RNA aptamers to regulate iron homeostasis in iron overload disorders$255,236
R43 · FY2022 · DK
Circular RNA as a platform for genome-wide microRNA sponge libraries$225,000
R43 · FY2020 · HG
Using highly expressed circular RNAs to substantially enhance protein expression yields in mammalian cells$225,000
R43 · FY2020 · GM